Get our latest issue now

available for iOS, Android & web

latest issue

Teva plans $500 million Japan acquisition - Nikkei

Daily News | May 05, 2011

Kevin Grogan

Teva plans $500 million Japan acquisition - Nikkei

Just after announcing a $6.8 billion takeover of Cephalon, Teva Pharmaceutical Industries is reportedly buying Japanese generics drugmaker Taiyo Pharmaceutical Industry.

The Nikkei newspaper says that the Israeli drugmaker will shell out 40 billion yen, or almost $500 million, to buy a majority stake in Japan's third-biggest generics group. Teva set up a Japanese unit in 2005 and established a generics joint venture with Kowa Co in September 2008.

The Nikkei claims that Teva is looking to mainly use Taiyo for production and the Teva-Kowa JV for sales in the 800 billion yen Japanese generics market.

Click here to order a reprint of this news story.


Your Comments

Tell us what you think.

Twitter Go to @PharmaTimes

Find a job

Website Search

Search News Search Magazine

Business Insight


Competitions News


International Clinical Researcher of the Year 2016

Book your tickets today!